Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Howard L. Kaufman, MD, FACS
Department of Surgery
Rutgers Cancer Institute of New Jersey
New Brunswick, NJ
Authored Items
Talimogene Laherparepvec (T-VEC) as Cancer Immunotherapy
By
Sachin Jhawar, MD
;
Sharad Goyal, MD
;
Praveen K. Bommareddy, MS
;
Andrew Zloza, MD
;
Howard L. Kaufman, MD, FACS
Articles
Melanoma/Skin Cancer
Read More ›
The Cancer Immunotherapy Trials Network: A National Strategy for the Development and Implementation of Immunotherapy for the Treatment of Cancer
By
Howard L. Kaufman, MD, FACS
Articles
Immunotherapy
Read More ›